Advent France Biotechnology
Paris, Île-de-Franceadbio.partners
Overview
Advent France Biotechnology is a venture capital firm that invests in a range of sectors within the life sciences - specifically in therapeutics-oriented projects. AFB's unique strategy combines early-stage investments in promising enterprises and strong entrepreneurial support to strengthen the company's growth. As an early-stage investor, they act as a catalyst to create companies based on innovations coming from academic research. They have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of a strong network of scientific, clinical, industry and financial partners.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ARTHEx Biotech | Sep 2025 | Series B | Co-investor |
| IntegraTherapeutics | Sep 2025 | VC Round | Co-investor |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| Augustine Therapeutics | Jun 2024 | Series A | Co-investor |
| Astraveus | Jun 2023 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.